{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:18:26Z","timestamp":1794003506717,"version":"4.8.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.josat.2026.209888","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T16:58:49Z","timestamp":1769014729000},"page":"209888","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Differences in MOUD receipt by legal referral type in outpatient treatment"],"prefix":"10.1016","volume":"184","author":[{"given":"John","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Renn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Veeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Beeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2026.209888_bb0005","author":"American Civil Liberties Union"},{"issue":"1","key":"10.1016\/j.josat.2026.209888_bb0010","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/08897077.2021.1944957","article-title":"Stigmatization of medications for opioid use disorder in 12-step support groups and participant responses","volume":"43","author":"Andraka-Christou","year":"2022","journal-title":"Substance Abuse"},{"issue":"12","key":"10.1016\/j.josat.2026.209888_bb0015","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/MLR.0000000000000803","article-title":"Medicaid coverage of methadone maintenance and the use of opioid agonist therapy among pregnant women in specialty treatment","volume":"55","author":"Bachhuber","year":"2017","journal-title":"Medical Care"},{"key":"10.1016\/j.josat.2026.209888_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.dadr.2024.100239","article-title":"Prevalence and predictors of medication for opioid use disorder among reproductive-aged women","volume":"11","author":"Bello","year":"2024","journal-title":"Drug and Alcohol Dependence Reports"},{"issue":"2 Suppl","key":"10.1016\/j.josat.2026.209888_bb0025","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.36076\/ppj.2008\/11\/S105","article-title":"Opioid complications and side effects","volume":"11","author":"Benyamin","year":"2008","journal-title":"Pain Physician"},{"issue":"12","key":"10.1016\/j.josat.2026.209888_bb0030","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1111\/add.15077","article-title":"The association of criminal justice supervision setting with overdose mortality: A longitudinal cohort study","volume":"115","author":"Binswanger","year":"2020","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.josat.2026.209888_bb0035","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.2732","article-title":"Prison buprenorphine implementation and postrelease opioid use disorder outcomes","volume":"7","author":"Bovell-Ammon","year":"2024","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2026.209888_bb0040","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.addbeh.2018.02.024","article-title":"Criminal justice continuum for opioid users at risk of overdose","volume":"86","author":"Brinkley-Rubinstein","year":"2018","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.josat.2026.209888_bb0045","series-title":"Drug use, dependence, and abuse among state prisoners and jail inmates, 2007\u20132009","author":"Bronson","year":"2017"},{"key":"10.1016\/j.josat.2026.209888_bb0050","series-title":"Correctional populations in the United States, 2021\u2014Statistical tables","author":"Carson","year":"2023"},{"issue":"26","key":"10.1016\/j.josat.2026.209888_bb0055","first-page":"719","article-title":"Demographic and substance use trends among heroin users\u2014United States, 2002\u20132013","volume":"64","author":"Centers for Disease Control and Prevention","year":"2015","journal-title":"Morbidity and Mortality Weekly Report"},{"issue":"2","key":"10.1016\/j.josat.2026.209888_bb0060","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/jama.2008.976","article-title":"Treating drug abuse and addiction in the criminal justice system: Improving public health and safety","volume":"301","author":"Chandler","year":"2009","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.josat.2026.209888_bb0065","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/ajad.12998","article-title":"Predictors of medication utilization for opioid use disorder among Medicaid-insured HIV patients in New York","volume":"29","author":"Choi","year":"2020","journal-title":"The American Journal on Addictions"},{"issue":"2","key":"10.1016\/j.josat.2026.209888_bb0070","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/HRP.0000000000000075","article-title":"Medication-assisted treatment of opioid use disorder: Review of the evidence and future directions","volume":"23","author":"Connery","year":"2015","journal-title":"Harvard Review of Psychiatry"},{"issue":"6","key":"10.1016\/j.josat.2026.209888_bb0075","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1037\/ort0000643","article-title":"Barriers to drug treatment in police diversion programs and drug courts: A qualitative analysis","volume":"92","author":"Dickson-Gomez","year":"2022","journal-title":"American Journal of Orthopsychiatry"},{"issue":"8","key":"10.1016\/j.josat.2026.209888_bb0080","article-title":"Disparities in medication use for criminal justice system\u2013referred opioid use disorder treatment","volume":"5","author":"Donahoe","year":"2024","journal-title":"JAMA Health Forum"},{"issue":"25","key":"10.1016\/j.josat.2026.209888_bb0085","doi-asserted-by":"crossref","first-page":"567","DOI":"10.15585\/mmwr.mm7325a1","article-title":"Treatment for opioid use disorder: Population estimates \u2014 United States, 2022","volume":"73","author":"Dowell","year":"2024","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"issue":"1","key":"10.1016\/j.josat.2026.209888_bb0090","doi-asserted-by":"crossref","DOI":"10.1186\/s40352-019-0100-2","article-title":"Advancing the implementation and sustainment of medication assisted treatment for opioid use disorders in prisons and jails","volume":"7","author":"Ferguson","year":"2019","journal-title":"Health & Justice"},{"key":"10.1016\/j.josat.2026.209888_bb0095","series-title":"Information about medications for opioid use disorder (MOUD)","author":"Food and Drug Administration","year":"2024"},{"issue":"1","key":"10.1016\/j.josat.2026.209888_bb0100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/08897077.2011.611460","article-title":"Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): Availability, barriers, and intentions","volume":"33","author":"Friedmann","year":"2012","journal-title":"Substance Abuse"},{"key":"10.1016\/j.josat.2026.209888_bb0105","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jsat.2014.10.001","article-title":"Effect of an organizational linkage intervention on staff perceptions of medication-assisted treatment and referral intentions in community corrections","volume":"50","author":"Friedmann","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2026.209888_bb0110","series-title":"Justice and treatment innovation: The drug court movement (NCJ 149260)","author":"Goldkamp","year":"1994"},{"key":"10.1016\/j.josat.2026.209888_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102768","article-title":"A scoping review of barriers and facilitators to implementation of medications for treatment of opioid use disorder within the criminal justice system","volume":"81","author":"Grella","year":"2020","journal-title":"International Journal of Drug Policy"},{"issue":"9","key":"10.1016\/j.josat.2026.209888_bb0120","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1177\/0093854819846528","article-title":"Substance use disorder treatment in the reentry environment: Service receipt and prisoner community reintegration","volume":"46","author":"Hamilton","year":"2019","journal-title":"Criminal Justice and Behavior"},{"key":"10.1016\/j.josat.2026.209888_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108504","article-title":"National trends in substance use treatment admissions for opioid use disorder among adults experiencing homelessness","volume":"132","author":"Han","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2026.209888_bb0130","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1080\/08897077.2021.1949664","article-title":"Disparities in receipt of medications for opioid use disorder among pregnant women","volume":"43","author":"Henkhaus","year":"2022","journal-title":"Substance Abuse"},{"issue":"4","key":"10.1016\/j.josat.2026.209888_bb0135","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/0093854819898219","article-title":"Drug testing and community supervision outcomes","volume":"47","author":"Hicks","year":"2020","journal-title":"Criminal Justice and Behavior"},{"issue":"2","key":"10.1016\/j.josat.2026.209888_bb0140","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1177\/0032885506287951","article-title":"Recidivism following mandated residential substance abuse treatment for felony probationers","volume":"86","author":"Hiller","year":"2006","journal-title":"The Prison Journal"},{"key":"10.1016\/j.josat.2026.209888_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.103050","article-title":"Reporting of substance use treatment quality in United States adult drug courts","volume":"90","author":"Joudrey","year":"2021","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"10.1016\/j.josat.2026.209888_bb0150","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-024-18133-5","article-title":"Contextualizing medications for opioid use disorder and peer support service provision in the probation system with implementation science","volume":"24","author":"Kang","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/j.josat.2026.209888_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2023.208960","article-title":"Racial\/ethnic differences in medication for addiction treatment for opioid use disorders among pregnant women in treatment facilities supported by state funds","volume":"148","author":"Kitsantas","year":"2023","journal-title":"Journal of Substance Use and Addiction Treatment"},{"key":"10.1016\/j.josat.2026.209888_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2023.107647","article-title":"A call to action: Contingency management to improve post-release treatment engagement among people with opioid use disorder who are incarcerated","volume":"176","author":"Klemperer","year":"2023","journal-title":"Preventive Medicine"},{"key":"10.1016\/j.josat.2026.209888_bb2000","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2023.209103","article-title":"The impact of the implementation of medication for opioid use disorder and COVID-19 in a statewide correctional system on treatment engagement, postrelease continuation of care, and overdose","volume":"152","author":"Klemperer","year":"2023","journal-title":"Journal of Substance Use and Addiction Treatment"},{"issue":"2","key":"10.1016\/j.josat.2026.209888_bb0165","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/0022042612462219","article-title":"Offender perceptions of mandated substance abuse treatment: An exploratory analysis of offender experiences in a community-based treatment program","volume":"43","author":"Kras","year":"2013","journal-title":"Journal of Drug Issues"},{"issue":"12","key":"10.1016\/j.josat.2026.209888_bb0170","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1377\/hlthaff.2017.0890","article-title":"Only one in twenty justice-referred adults in specialty treatment for opioid use receive methadone or buprenorphine","volume":"36","author":"Krawczyk","year":"2017","journal-title":"Health Affairs"},{"key":"10.1016\/j.josat.2026.209888_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107997","article-title":"Opioid overdose death following criminal justice involvement: Linking statewide corrections and hospital databases to detect individuals at highest risk","volume":"213","author":"Krawczyk","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2026.209888_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108329","article-title":"Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings","volume":"126","author":"Krawczyk","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2026.209888_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107732","article-title":"Prevalence and treatment of opioid use disorders among primary care patients in six health systems","volume":"207","author":"Lapham","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.josat.2026.209888_bb0190","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1177\/00220426211000330","article-title":"Diversion programs for individuals who use substances: A review of the literature","volume":"51","author":"Lindquist-Grantz","year":"2021","journal-title":"Journal of Drug Issues"},{"key":"10.1016\/j.josat.2026.209888_bb0195","doi-asserted-by":"crossref","first-page":"112886","DOI":"10.1016\/j.drugalcdep.2025.112886","article-title":"Trends of all opioid-, heroin-, and fentanyl-involved nonfatal overdoses in the United States, October 2020\u2013April 2025","author":"Liu","year":"2025","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2026.209888_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2022.108850","article-title":"Drug court utilization of medications for opioid use disorder in high opioid mortality communities","volume":"141","author":"Marlowe","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2026.209888_bb0205","series-title":"Opioid use disorder screening and treatment in local jails, 2019","author":"Maruschak","year":"2023"},{"key":"10.1016\/j.josat.2026.209888_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103823","article-title":"Jail-based reentry programming to support continued treatment with medications for opioid use disorder: Qualitative perspectives and experiences among jail staff in Massachusetts","volume":"109","author":"Matsumoto","year":"2022","journal-title":"International Journal of Drug Policy"},{"issue":"5","key":"10.1016\/j.josat.2026.209888_bb0215","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jsat.2012.10.004","article-title":"Medication assisted treatment in US drug courts: Results from a nationwide survey of availability, barriers and attitudes","volume":"44","author":"Matusow","year":"2013","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1016\/j.josat.2026.209888_bb0220","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.3821","article-title":"Use of medication for opioid use disorder among US adolescents and adults with need for opioid treatment, 2019","volume":"5","author":"Mauro","year":"2022","journal-title":"JAMA Network Open"},{"issue":"1","key":"10.1016\/j.josat.2026.209888_bb0230","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s12103-015-9324-4","article-title":"Opiate treatment in the criminal justice system: A review of CrimeSolutions.gov evidence rated programs","volume":"41","author":"Miller","year":"2016","journal-title":"American Journal of Criminal Justice"},{"key":"10.1016\/j.josat.2026.209888_bb0235","series-title":"Trends in non-medical prescription opioid and heroin co-use and medication assisted treatment utilization [Doctoral dissertation, Emory University]","author":"Mital","year":"2018"},{"key":"10.1016\/j.josat.2026.209888_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2022.114992","article-title":"Geographic disparities in access to medication for opioid use disorder across US census tracts based on treatment utilization behavior","volume":"302","author":"Mitchell","year":"2022","journal-title":"Social Science & Medicine"},{"key":"10.1016\/j.josat.2026.209888_bb0245","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jsat.2018.12.003","article-title":"Effectiveness of medication assisted treatment for opioid use in prison and jail settings: A meta-analysis and systematic review","volume":"99","author":"Moore","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2026.209888_bb0250","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1037\/ser0000293","article-title":"Reentry interventions that address substance use: A systematic review","volume":"17","author":"Moore","year":"2020","journal-title":"Psychological Services"},{"issue":"3","key":"10.1016\/j.josat.2026.209888_bb0255","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/0032885511409896","article-title":"A description of the self-identified needs, service expenditures, and social outcomes of participants of a prisoner-reentry program","volume":"91","author":"Morani","year":"2011","journal-title":"The Prison Journal"},{"issue":"1","key":"10.1016\/j.josat.2026.209888_bb0260","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/10826084.2023.2257319","article-title":"Opioid misuse and associated health risks among adults on probation and parole: Prevalence and correlates 2015\u20132020","volume":"59","author":"Morrison","year":"2023","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.josat.2026.209888_bb0270","first-page":"109","article-title":"As stated by criminal justice professionals: Perceptions and barriers related to medication-assisted treatment","volume":"2","author":"Neal","year":"2019","journal-title":"Journal of Advancing Justice"},{"issue":"3","key":"10.1016\/j.josat.2026.209888_bb0275","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.sapharm.2023.12.001","article-title":"Is there a disparity in medications for opioid use disorder based on race\/ethnicity and gender? A systematic review and meta-analysis","volume":"20","author":"Nedjat","year":"2024","journal-title":"Research in Social and Administrative Pharmacy"},{"issue":"6","key":"10.1016\/j.josat.2026.209888_bb0285","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1377\/hlthaff.2019.01622","article-title":"Buprenorphine treatment by primary care providers, psychiatrists, addiction specialists, and others: Trends in buprenorphine treatment by prescriber specialty\u2014Primary care providers, psychiatrists, and addiction medicine specialists","volume":"39","author":"Olfson","year":"2020","journal-title":"Health Affairs"},{"key":"10.1016\/j.josat.2026.209888_bb0290","series-title":"National and regional trends in fentanyl seizures in the United States, with emphasis on pressed-pill forms","author":"Palamar","year":"2025"},{"key":"10.1016\/j.josat.2026.209888_bb0295","series-title":"When prisoners come home: Parole and prisoner reentry","author":"Petersilia","year":"2003"},{"issue":"1","key":"10.1016\/j.josat.2026.209888_bb0300","first-page":"15","article-title":"Facilitators and barriers to collaboration between drug courts and medication-for-opioid-use-disorder (MOUD) treatment providers","volume":"11","author":"Pivovarova","year":"2023","journal-title":"Health & Justice"},{"issue":"2","key":"10.1016\/j.josat.2026.209888_bb0305","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/ADM.0000000000001420","article-title":"Collaborating with jails to provide community-based medication for opioid use disorder: Qualitative perspectives from MOUD treatment providers","volume":"19","author":"Pivovarova","year":"2025","journal-title":"Journal of Addiction Medicine"},{"issue":"3","key":"10.1016\/j.josat.2026.209888_bb0310","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11292-009-9077-5","article-title":"Adherence to scheduled sessions in a randomized field trial of case management: The criminal justice\u2013Drug abuse treatment studies transitional case management study","volume":"5","author":"Prendergast","year":"2009","journal-title":"Journal of Experimental Criminology"},{"key":"10.1016\/j.josat.2026.209888_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2022.108751","article-title":"Developing a cascade of care for opioid use disorder among individuals in jail","volume":"138","author":"Ray","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2026.209888_bb0320","doi-asserted-by":"crossref","DOI":"10.1186\/s40352-024-00291-8","article-title":"Linkage facilitation for opioid use disorder in criminal legal system contexts: A primer for researchers, clinicians, and legal practitioners","volume":"12","author":"Satcher","year":"2024","journal-title":"Health & Justice"},{"issue":"5","key":"10.1016\/j.josat.2026.209888_bb0325","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/10509674.2024.2370286","article-title":"The effect of drug treatment court on recidivism: A comparison with traditional court intervention","volume":"63","author":"Sheeran","year":"2024","journal-title":"Journal of Offender Rehabilitation"},{"issue":"4","key":"10.1016\/j.josat.2026.209888_bb0330","first-page":"560","article-title":"Impact of Medicaid, race\/ethnicity, and criminal justice referral on opioid use disorder treatment","volume":"50","author":"Sledge","year":"2022","journal-title":"The Journal of the American Academy of Psychiatry and the Law"},{"key":"10.1016\/j.josat.2026.209888_bb0335","article-title":"Treatment outcomes associated with medications for opioid use disorder (MOUD) among criminal justice-referred admissions to residential treatment in the US, 2015\u20132018","volume":"236, Article 109498","author":"Stahler","year":"2022","journal-title":"Drug and Alcohol Dependence"},{"issue":"9","key":"10.1016\/j.josat.2026.209888_bb0340","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/aje\/kwp026","article-title":"Multiple imputation with large data sets: A case study of the children\u2019s mental health initiative","volume":"169","author":"Stuart","year":"2009","journal-title":"American Journal of Epidemiology"},{"key":"10.1016\/j.josat.2026.209888_bb0345","article-title":"Medications for opioid use disorder","author":"Substance Abuse and Mental Health Services Administration","year":"2021"},{"key":"10.1016\/j.josat.2026.209888_bb0350","author":"Substance Abuse and Mental Health Services Administration"},{"key":"10.1016\/j.josat.2026.209888_bb0355","series-title":"Clinical issues in intensive outpatient treatment for substance use disorders (Advisory No. PEP20-02-01-021)","author":"Substance Abuse and Mental Health Services Administration","year":"2021"},{"key":"10.1016\/j.josat.2026.209888_bb0360","series-title":"Medications for opioid use disorder: An effective treatment for justice-involved persons reentering the community (Publication No. PEP24-02-006)","author":"Substance Abuse and Mental Health Services Administration","year":"2024"},{"key":"10.1016\/j.josat.2026.209888_bb0365","series-title":"2024 national survey on mental health and substance use \u2014 Annual detailed tables","author":"Substance Abuse and Mental Health Services Administration","year":"2024"},{"issue":"6","key":"10.1016\/j.josat.2026.209888_bb0370","doi-asserted-by":"crossref","first-page":"124","DOI":"10.15585\/mmwr.mm7306a2","article-title":"Routes of drug use among drug overdose deaths \u2014 United States, 2020\u20132022","volume":"73","author":"Tanz","year":"2024","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"issue":"3","key":"10.1016\/j.josat.2026.209888_bb0375","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/15564886.2010.485903","article-title":"Probation and diversion: Is there a place at the table and what should we serve?","volume":"5","author":"Taxman","year":"2010","journal-title":"Victims & Offenders"},{"key":"10.1016\/j.josat.2026.209888_bb0380","series-title":"But they all come back: Facing the challenges of prisoner reentry","author":"Travis","year":"2005"},{"issue":"1","key":"10.1016\/j.josat.2026.209888_bb0385","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10488-014-0623-8","article-title":"Effects of an organizational linkage intervention on inter-organizational service coordination between probation\/parole agencies and community treatment providers","volume":"43","author":"Welsh","year":"2016","journal-title":"Administration and Policy in Mental Health and Mental Health Services Research"},{"issue":"5","key":"10.1016\/j.josat.2026.209888_bb0390","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1377\/hlthaff.2019.01021","article-title":"Self-help groups and medication use in opioid addiction treatment: A national analysis","volume":"39","author":"Wen","year":"2020","journal-title":"Health Affairs"},{"key":"10.1016\/j.josat.2026.209888_bb0395","article-title":"Health, polysubstance use, and criminal justice involvement among adults with varying levels of opioid use","volume":"1(3), Article e180558","author":"Winkelman","year":"2018","journal-title":"JAMA Network Open"},{"issue":"4","key":"10.1016\/j.josat.2026.209888_bb0400","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/00952990.2019.1605372","article-title":"The case for a medication first approach to the treatment of opioid use disorder","volume":"45","author":"Winograd","year":"2019","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.josat.2026.209888_bb0405","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fpubh.2019.00193","article-title":"A biopsychosocial overview of the opioid crisis: Considering nutrition and gastrointestinal health","volume":"7","author":"Wiss","year":"2019","journal-title":"Frontiers in Public Health"},{"issue":"7","key":"10.1016\/j.josat.2026.209888_bb0410","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1177\/0887403417731802","article-title":"Drug court through the eyes of participants","volume":"30","author":"Witkin","year":"2019","journal-title":"Criminal Justice Policy Review"},{"issue":"12","key":"10.1016\/j.josat.2026.209888_bb0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226349","article-title":"Differences in receipt of opioid agonist treatment and time to enter treatment for opioid use disorder among specialty addiction programs in the United States, 2014-17","volume":"14","author":"Yang","year":"2019","journal-title":"PLoS One"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926000081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926000081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T03:26:28Z","timestamp":1772681188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875926000081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":81,"alternative-id":["S2949875926000081"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2026.209888","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences in MOUD receipt by legal referral type in outpatient treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2026.209888","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"209888"}}